cenisertib

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug Namecenisertib
Drug Alias NameR-763R-945763AS-703569MSC-1992371A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase Aurora-A inhibitorsSerine/threonine-protein kinase Aurora-C inhibitorsSerine/threonine-protein kinase Aurora-B inhibitors
TargetsSerine/threonine-protein kinase Aurora-ASerine/threonine-protein kinase Aurora-CSerine/threonine-protein kinase Aurora-B
Therapy Area/IndicationsSolid tumoursHematologic NeoplasmsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesItaly +[6] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesRigel Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEmd Serono IncMerck KGaA, Darmstadt, Germany
Active IndicationsN/A
Inactive IndicationsSolid tumoursHematologic NeoplasmsPancreatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A